Page 192 - EJMO-9-3
P. 192

Eurasian Journal of
            Medicine and Oncology                                                  Research on DSY in treating gastritis



               macrophages. J Proteome Res. 2021;20(7):3734-3748.     doi: 10.1016/j.biopha.2024.116912
               doi: 10.1021/acs.jproteome.1c00325              48.  Liu X, Wang S, Li J, Zhang J, Liu D. Regulatory effect of
            42.  Wu C, Zhao W, Zhang X, Chen X. Neocryptotanshinone   traditional Chinese medicines on signaling pathways of
               inhibits lipopolysaccharide-induced inflammation in   process from chronic atrophic gastritis to gastric cancer.
               RAW264.7 macrophages by suppression of NF-κB and iNOS   Chin Herb Med. 2022;14(1):5-19.
               signaling pathways. Acta Pharm Sin B. 2015;5(4):323-329.     doi: 10.1016/j.chmed.2021.10.008
               doi: 10.1016/j.apsb.2015.01.010                 49.  Nagura H, Ohtani H, Sasano H, Matsumoto T. The immuno-
            43.  Wu YH, Wu YR, Li B, Yan ZY. Cryptotanshinone: A review   inflammatory mechanism for tissue injury in inflammatory
               of its pharmacology activities and molecular mechanisms.   bowel disease and helicobacter pylori-infected chronic
               Fitoterapia. 2020;145:104633.                      active gastritis. Roles of the mucosal immune system.
                                                                  Digestion. 2001;63 Suppl 1:12-21.
               doi: 10.1016/j.fitote.2020.104633
                                                                  doi: 10.1159/000051905
            44.  Yoo SR, Jeong SJ, Lee NR, Shin HK, Seo CS. Simultaneous
               determination and anti-inflammatory effects of four   50.  Nakamura H, Mukai E, Hirano D, Matsuhisa T, Yamada N,
               phenolic compounds in dendrobii herba.  Nat Prod Res.   Yoshino  S.  Gastrointestinal  disorder  and  helicobacter
               2017;31(24):2923-2926.                             pylori infection in patients with rheumatoid arthritis. Mod
               doi: 10.1080/14786419.2017.1300798                 Rheumatol. 2001;11(1):23-27.
            45.  Zhang J, Zhang Q, Liu G, Zhang N. Therapeutic potentials      doi: 10.3109/s101650170039
               and mechanisms of the Chinese traditional medicine   51.  Polat A, Cinel L, Dusmez D, Aydin O, Egilmez R. Expression
               danshensu. Eur J Pharmacol. 2019;864:172710.       of cell-cycle related proteins in helicobacter pylori gastritis
               doi: 10.1016/j.ejphar.2019.172710                  and association with gastric carcinoma.  Neoplasma.
                                                                  2002;49(2):95-100.
            46.  Zhang T, Lu SH, Bi Q, et al. Volatile oil from amomi fructus
               attenuates 5-fluorouracil-induced intestinal mucositis. Front      doi: 10.1038/sj.neo.7900211
               Pharmacol. 2017;8:786.                          52.  Suzuki  T,  Ina  K,  Nishiwaki  T,  et al.  Differential  roles
               doi: 10.3389/fphar.2017.00786                      of interleukin-1beta and interleukin-8 in neutrophil
                                                                  transendothelial migration in patients with helicobacter
            47.  Jia JH, Zhao H, Li F, et al. Research on drug treatment and
               the novel signaling pathway of chronic atrophic gastritis.   pylori infection. Scand J Gastroenterol. 2004;39(4):313-321.
               Biomed Pharmacother. 2024;176:116912.              doi: 10.1080/00365520310008610




































            Volume 9 Issue 3 (2025)                        184                         doi: 10.36922/EJMO025160124
   187   188   189   190   191   192   193   194   195   196   197